Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maher

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Molecular Immunology|October 24, 2007
Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activationAgnes Shuk Yee Lo, Jessica Rhiannon Taylor, Farzin Farzaneh, et al.
Journal of Medicinal Chemistry|February 2, 2018
A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-Guided SurgeryZhi Lu, Truc Thuy Pham, Vineeth Rajkumar, et al.
Cancers|November 12, 2013
Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancerRobert Goldstein, Charles Hanley, Jonathan Morris, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
British Journal of Cancer|March 6, 2026
Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cellsAlexandria R Mitchell, Yiran Chen, Giuseppe Pugliese, et al.
Frontiers in Oncology|March 25, 2021
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma CellsNattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
International Journal of Mental Health Nursing|June 20, 2018
Our Sunshine place: A collective narrative and reflection on the experiences of a mental health crisis leading to an admission to a psychiatric inpatient unitMarianne Wyder, Helena Roennfeldt, Rise Faith Rosello, et al.
Human Gene Therapy. Clinical Development|October 9, 2013
Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancerMay C I van Schalkwyk, Sophie E Papa, Jean-Pierre Jeannon, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 14, 2024
Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinomaKwanpirom Suwanchiwasiri, Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Molecular Immunology|October 24, 2007
Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activationAgnes Shuk Yee Lo, Jessica Rhiannon Taylor, Farzin Farzaneh, et al.
Journal of Medicinal Chemistry|February 2, 2018
A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-Guided SurgeryZhi Lu, Truc Thuy Pham, Vineeth Rajkumar, et al.
Cancers|November 12, 2013
Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancerRobert Goldstein, Charles Hanley, Jonathan Morris, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
British Journal of Cancer|March 6, 2026
Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cellsAlexandria R Mitchell, Yiran Chen, Giuseppe Pugliese, et al.
Frontiers in Oncology|March 25, 2021
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma CellsNattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
International Journal of Mental Health Nursing|June 20, 2018
Our Sunshine place: A collective narrative and reflection on the experiences of a mental health crisis leading to an admission to a psychiatric inpatient unitMarianne Wyder, Helena Roennfeldt, Rise Faith Rosello, et al.
Human Gene Therapy. Clinical Development|October 9, 2013
Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancerMay C I van Schalkwyk, Sophie E Papa, Jean-Pierre Jeannon, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 14, 2024
Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinomaKwanpirom Suwanchiwasiri, Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Pageof 14